Circulating tumor markers in breast cancer: accepted utilities and novel prospects.

Circulating tumor markers in breast cancer: accepted utilities and novel prospects.

Item
http://www.wikidata.org/entity/Q33538453
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerHypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasisHigh-mannose glycans are elevated during breast cancer progressionDNA methylation in thyroid tumorigenesis.Delineating an epigenetic continuum for initiation, transformation and progression to breast cancerSerum tumor markers in patients with breast cancer.Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersCEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET.Clinically Meaningful Use of Blood Tumor Markers in Oncology.HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
P2860

Circulating tumor markers in breast cancer: accepted utilities and novel prospects.

Item
http://www.wikidata.org/entity/Q33538453
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@ast
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@en
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@nl
type
label
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@ast
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@en
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@nl
prefLabel
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@ast
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@en
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P356
P1433
P1476
Circulating tumor markers in breast cancer: accepted utilities and novel prospects.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698